Navigation Links
Neurocrine Biosciences Reports First Quarter 2012 Results
Date:5/2/2012

hich began in June 2010. During the first quarter of 2012, the Company recognized revenue of $2.0 million in the form of sponsored development funding under these two agreements compared to $3.2 million of sponsored development revenue during the first quarter of 2011.

Research and development expenses increased to $9.4 million during the first quarter of 2012 compared with $7.3 million for the same period in 2011.  The increase in expense was a result of higher external clinical development expenses related to the VMAT2 program, partially offset by lower external clinical development expenses related to the elagolix program. The Company also incurred costs during the first quarter of 2012 related to early stage programs for external testing and scientific consulting that accounted for $0.7 million of the increase. Additionally, research and development personnel expenses were higher quarter over quarter, primarily due to a $0.3 million increase in share-based compensation expense. General and administrative expenses increased from $3.2 million in the first quarter of 2011 to $3.7 million for the first quarter of 2012. This increase is primarily driven by higher share-based compensation expense which increased by $0.4 million.

Pipeline HighlightsElagolix Update
During April 2012, Abbott held the investigator meeting to launch the Phase III program for elagolix in endometriosis. The screening of patients for the Phase III clinical program of elagolix for endometriosis is expected to commence in the second quarter of 2012.

Abbott continues to enroll subjects in a large Phase II study of elagolix in uterine fibroids. This study will assess uterine blood loss in 325 women with heavy uterine bleeding due to uterine fibroids.

VMAT2 Update
The Company's VMAT2 inhibitor, NBI-98854, recently completed a second Phase II study assessing the efficacy of NBI-98854 in tardive dyskinesia patients. The design of th
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Neurocrine Biosciences Reports First Quarter 2008 Results
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
5. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
6. Neurocrine Biosciences Presents Elagolix Data
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
8. Neurocrine Biosciences Reports Third Quarter 2009 Results
9. Neurocrine Advances VMAT2 Inhibitor Program
10. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Neurocrine Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...   Decision Resources Group finds that ... frequent dosing as the highest unmet need in ... on both patients and providers associated with monthly ... which are the current standard of care. The ... in development for dosing every two to three ...
(Date:7/2/2015)... , July 2, 2015  Konica Minolta, Inc. (Konica ... that it has acquired Sawae Technologica Ltda., an X-ray ... Brazil , through its Brazilian healthcare sales company, ... Local Brazil market ... increasing population exceeding 200 million, significant healthcare technical advancements ...
(Date:7/2/2015)... Ill. , July 2, 2015  AbbVie (NYSE: ... results on Friday, July 24, 2015, before the market ... of the earnings conference call at 8 a.m. Central ... AbbVie,s Investor Relations website at www.abbvieinvestor.com . An ... 11 a.m. Central time. About AbbVie ...
Breaking Medicine Technology:Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... treated with Satraplatin Demonstrated Statistically,Significant Improvement in ... March 22, 2007 /PRNewswire-FirstCall/ -- Pharmion,Corporation and ... from,the double-blind, randomized satraplatin Phase 3 registrational,trial, ... Cancer) which were presented today at the ...
... Scientists,at WEHI have made a discovery with potentially ... undergoing,cancer chemotherapy. , The research team led by ... platelet life span is controlled by two key,molecules. ... new,drug to prolong the life span of platelets ...
Cached Medicine Technology:Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 2Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 4Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 5Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 6Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 7Major Discovery Raises Prospect of Better Patient Care By Improving,Platelet Life Span 2Major Discovery Raises Prospect of Better Patient Care By Improving,Platelet Life Span 3
(Date:7/3/2015)... (PRWEB) , ... July 03, ... ... announced the sessions and speaker lineup for its 2015 Annual Conference ... place August 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, ...
(Date:7/3/2015)... ... 03, 2015 , ... The Erie County Bar Association Institute ... The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... investigating these types of cases. , Each year, New York State residents are ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ” was featured ... coolest technology products available to consumers. Amanda Forstrom, a technology expert and special reporter ... great for documenting memories. , Almost every smartphone has an incredibly powerful camera built ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce ... sweetFrog store located in the Lone Star State. The premium frozen yogurt chain was listed ... store, which opened June 19 in the Village at Bachman Lake, is located at:, 3701 ...
(Date:7/2/2015)... ... , ... Many Fourth of July celebrations will include fireworks this summer, so ... sharing some tips to promote the proper use of fireworks. , According to the ... daily with fireworks-related injuries in the month surrounding the Fourth of July. Amica is ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:6 Fireworks Safety Tips from Amica Insurance 2
... study suggests, , WEDNESDAY, Jan. 20 (HealthDay News) -- ... drills, say German researchers. , They found that firing ... tooth structure beneath the enamel coating -- reduced the ... results suggest that plasma jets could be used to ...
... ... , ... MD (Vocus) January 20, 2010 -- Healthy Directions, LLC, is proud to announce ... top quality natural solutions to today’s most pressing health concerns. The new Web ...
... CHICAGO , Jan. 20 According to ... American Journal of Health Promotion , a peer-reviewed journal devoted ... activities within an incentive-based health insurance wellness program had significantly ... data over one year of 948,974 adult members of ...
... benefit patients, survey reports , WEDNESDAY, Jan. 20 (HealthDay ... medical students think that knowledge of complementary and alternative ... , Complementary and alternative medicine, or CAM, includes ... , "Even with the high prevalence of CAM use ...
... ... decisions are substantiated by accurate data analysis and reporting, four colleges within the ... , ... NH (PRWEB) January 20, 2010 -- In today’s technology-driven environment, where sound business ...
... ... On January 2 of this year, Freedom From Covert Harassment and Surveillance ... This event coincides with January as National Stalking Awareness Month. Organized ... may not even know why the stalking is occurring, has emerged with ...
Cached Medicine News:Health News:Healthy Directions, LLC, Announces Launch of Online Resource for Premium Quality Natural Health Solutions 2Health News:Research Indicates Participants in Incentive-Based Health Promotion Programs Have Lower Healthcare Costs 2Health News:Research Indicates Participants in Incentive-Based Health Promotion Programs Have Lower Healthcare Costs 3Health News:Research Indicates Participants in Incentive-Based Health Promotion Programs Have Lower Healthcare Costs 4Health News:New Hampshire Community Colleges Choose Rapid Insight for Data Reporting Needs 2Health News:FFCHS Launches Online Petition Against Organized Stalking and Electronic Torture 2Health News:FFCHS Launches Online Petition Against Organized Stalking and Electronic Torture 3Health News:FFCHS Launches Online Petition Against Organized Stalking and Electronic Torture 4
... VACOPED is a revolutionary cast replacement system ... lower leg and foot. , ,A ... anatomy and in conjunction with a rigid ... general time of fracture or rupture healing ...
... therapeutic benefits of controlled compression and cold, ... pain. The anatomically designed cuff provides complete ... be ordered as a single cuff, or ... and insulation disk). The Cooler is available ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Qualcare™ Thumb Spica...
Medicine Products: